Global

Current NPS Threats

• Current NPS Threats Vol. VI/2023 - (EN), (ES)
• Current NPS Threats Vol. V/2022 - (EN), (ES)
• Current NPS Threats Vol. IV/2021 - (EN), (RU)
• Current NPS Threats Vol.III/2020 - (EN), (ES), (RU)
• Current NPS Threats Vol.II/2020 - (EN), (ES), (RU)
• Current NPS Threats Vol.I/2019 -  (EN)

Global SMART Updates (GSU)

• GSU Vol.26/2022 - Afghanistan's 'tablet K' - a forensic insight into an emerging synthetic drug market (EN), (ES), (RU) 
• GSU Vol.25/2021 - Regional diversity and the impact of scheduling on NPS trends (EN), (ES), (RU)
• GSU Vol.24/2020 - The growing complexity of the opioid crisis (EN), (ES), (RU)
• GSU Vol.23/2020 - An expanding synthetic drugs market – Implications for precursor control (EN), (ES), (RU) 
• GSU Vol.22/2019 - The ATS market - 10 years after the 2009 Plan of Action (EN), (ES), (RU) 
• GSU Vol.21/2019 - Understanding the global opioid crisis (EN), (ES), (RUS)
• GSU Vol.20/2018 - Methamphetamine continues to dominate synthetic drug markets (EN), (ES), (RU)
• GSU Vol.19/2018 - Understanding the synthetic drug market: the NPS factor (EN), (ES), (RU)
• GSU Vol.18/2017 - Non-medical use of benzodiazepines: a growing threat to public health? (EN), (ES), (RU)
• GSU Vol.17/2017 - Fentanyl and its analogues - 50 years on (EN), (ES), (RU)
• GSU Vol.16/2016 - Post-UNGASS 2016: NPS trends, challenges and recommendations (EN), (ES), (RU)
• GSU Vol.15/2016 - Injecting use of synthetic drugs (EN), (ES), (RU)
• GSU Vol.14/2015 - Legal responses to NPS: Multiple approaches to a multi-faceted problem (EN), (ES), (RU)
• GSU Vol.13/2015 - Synthetic cannabinoids: Key facts about the largest and most dynamic group of NPS (EN), (ES), (RU)
• GSU Vol.12/2014 - Methamphetamine manufacture: Global Patterns and Regional Differences (EN), (ES), (RU)
• GSU Vol.11/2014 - The changing nature of “ecstasy” (EN), (ES), (RU)

Global Synthetic Drugs Assessment

• 2020 - Global Synthetic Drugs Assessment (EN), (Hindi)
• 2017 - Global Synthetic Drugs Assessment - Amphetamine Type Substances and new psychoactive substances (EN)
• 2014 - Global Synthetic Drugs Assessment - Amphetamine Type Substances and new psychoactive substances (EN)

Asia

Synthetic Drugs in Central Asia

• 2017 - Central Asia Synthetic Drugs Situation Assessment (EN), (RU)

Synthetic Drugs in East and South-East Asia

• 2021 - Synthetic Drugs in East and South-East Asia: Latest developments and challenges (EN), (Chinese)
• 2020 - Synthetic Drugs in East and South-East Asia: Latest developments and challenges (EN)
• 2019 - Synthetic Drugs in East and South-East Asia: Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances (EN) 
• 2017 - The Challenge of Synthetic Drugs in East and South-East Asia - Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances  (EN) 
• 2015 - The Challenge of Synthetic Drugs in East and South-East Asia and Oceania - Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances (EN) 

Americas 

Synthetic Drugs in Latin America and the Caribbean

• 2014 - Amphetamine-type Stimulants in Latin America (EN) (ES)

Leaflets and Posters

• 2018: UNODC Early Warning Advisory (EWA) Toxicology Portal leaflet (EN)

Selected Scientific Literature 

• Selected scientific articles 2021/2 (July to December) (EN)
• Selected scientific articles 2021/1 (January to June) (EN)
• Selected scientific articles 2020/2 (July to December) (EN)
• Selected scientific articles 2020/1 (January to June) (EN)
• Selected scientific articles 2019/2 (July to December) (EN)
• Selected scientific articles 2019/1 (January to June) (EN)
• Selected scientific articles 2018/2 (July to December) (EN)
• Selected scientific articles 2018/1 (January to June) (EN)

Presentations

• Changes in the scope of control of substances - Control Regimes (EN)
• Early Warning Systems on NPS - Examples from Chile, Sweden, the European Union and UNODC (EN)

Conference Room Paper

• 2016: New psychoactive substances: overview of trends, challenges and legal approaches, 2016 (EN)
• 2015:UNODC-WHO Expert Consultation on New Psychoactive Substances, 2015 (EN)